Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

0.915
Delayed Data
As of Jun 23
 -0.075 / -7.58%
Today’s Change
0.86
Today|||52-Week Range
5.74
-59.33%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.99
Today’s open0.99
Day’s range0.90 - 1.04
Volume4,554,369
Average volume (3 months)1,003,465
Market cap$48.7M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+20.97%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
ITEKInotek Pharmaceutica...-0.10-5.26%
SCYXSCYNEXIS Inc-0.01-0.52%
CTRVContraVir Pharmaceut...-0.00-0.63%
BLPHBellerophon Therapeu...+0.08+5.84%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts